
Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1–derived oncolytic immunotherapy
Harrington, Kevin J., Puzanov, Igor, Hecht, J. Randolph, Hodi, F. Stephen, Szabo, Zsolt, Murugappan, Swami, Kaufman, Howard L.Langue:
english
Journal:
Expert Review of Anticancer Therapy
DOI:
10.1586/14737140.2015.1115725
Date:
November, 2015
Fichier:
PDF, 932 KB
english, 2015